<DOC>
	<DOCNO>NCT02169323</DOCNO>
	<brief_summary>There grow evidence non-eosinophilic asthmatic less sensitive inhaled corticosteroid ( ICS ) eosinophilic asthmatic . As non-eosinophilic asthmatic patient treat ICS accord international guideline asthma , investigator would like investigate whether stepping-down ICS patient may safe . Indeed , investigator reasonably expect progressive cessation ICS possible patient without clinical worsening .</brief_summary>
	<brief_title>Step-down Inhaled Corticosteroids ( ICS ) Non-eosinophilic Asthmatics</brief_title>
	<detailed_description>For patient whose asthma control begin study , step-up treatment plan step 4 Global Initiative Asthma ( GINA ) . This step-up last 3 month permit ensure patient achieve best possible level asthma control . A progressive step-down inhaled corticosteroid ( ICS ) achieve . For patient whose asthma control begin study , progressive step-down ICS directly achieve . The progressive step-down ICS dose undertaken every 3 month accord dose level define GINA guideline ( high low daily dose ) complete cessation ICS 6 month . Other associated asthma treatment asthma keep unchanged . At quarterly visit , clinical composite outcome measure , patient . This composite outcome include score asthma control questionnaire ( ACQ ) number exacerbation . This outcome determine visit patient continue study ( success criterion ) stop study ( failure criterion ) . The success criterion define section `` Current Primary Outcome ''</detailed_description>
	<criteria>At least 18 year age Physiciandiagnosed asthma base presence typical symptom ( wheeze , breathlessness , chest tightness , cough ) Asthma confirm : Forced expiratory volume 1 second ( FEV1 ) increase least 12 % 200 mL inhalation 400 mcg salbutamol And/or provocative concentration methacholine cause 20 % fall FEV1 ( PC20M ) less 16 mg/ml Sputum eosinophils rate le 3 % Absolute blood eosinophil count le 400 per mm3 Treatment stable dose inhale corticosteroid ( ICS ) previous three month High risk asthmarelated death , define : Nearfatal asthma history , require stay intensive care unit Current use recent discontinuation ( four week ) oral corticosteroid ( OCS ) Treatment omalizumab Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Non-eosinophilic Asthma</keyword>
	<keyword>Inhaled corticosteroid</keyword>
	<keyword>Step-down</keyword>
</DOC>